Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Takenaga

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Prophylaxis for post-operative thrombosis]Katsue Asakawa, Noriko Takenaga, Ken Takizawa
Cancer Science|October 6, 2025
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case ReportMaako Kawamura, Hiroshi Tada, Hidekazu Shirota, et al.
Oncology|October 30, 2023
Comparison of Efficacy and Safety between Carboplatin-Etoposide and Cisplatin-Etoposide Combination Therapy in Patients with Advanced Neuroendocrine Carcinoma: A Retrospective StudyHiroo Imai, Ken Saijo, Yoshifumi Kawamura, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case ReportHiroo Imai, Ken Saijo, Noriko Takenaga, et al.
Anticancer Research|November 29, 2023
FOLFIRI Chemotherapy for Patients With Metastatic Urachal CarcinomaSakura Hiraide Taniguchi, Keigo Komine, Noriko Takenaga, et al.
Internal Medicine (Tokyo, Japan)|June 12, 2024
Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks Is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway InhibitorsYuya Yoshida, Masanobu Takahashi, Keigo Komine, et al.
The Tohoku Journal of Experimental Medicine|February 12, 2025
Outcomes of Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Study Using Real-World DataTomoyuki Iwasaki, Masanobu Takahashi, Kota Ouchi, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|November 13, 2004
[Prophylaxis for post-operative thrombosis]Katsue Asakawa, Noriko Takenaga, Ken Takizawa
Cancer Science|October 6, 2025
Emergence of PALB2 Reversion Mutations as a Mechanism of Resistance to Niraparib in Breast Cancer: A Case ReportMaako Kawamura, Hiroshi Tada, Hidekazu Shirota, et al.
Oncology|October 30, 2023
Comparison of Efficacy and Safety between Carboplatin-Etoposide and Cisplatin-Etoposide Combination Therapy in Patients with Advanced Neuroendocrine Carcinoma: A Retrospective StudyHiroo Imai, Ken Saijo, Yoshifumi Kawamura, et al.
Current Oncology (Toronto, Ont.)|March 27, 2024
Chylous Ascites Associated with Advanced Pancreatic Cancer That Improved with Appropriate Treatment: A Case ReportHiroo Imai, Ken Saijo, Noriko Takenaga, et al.
Anticancer Research|November 29, 2023
FOLFIRI Chemotherapy for Patients With Metastatic Urachal CarcinomaSakura Hiraide Taniguchi, Keigo Komine, Noriko Takenaga, et al.
Internal Medicine (Tokyo, Japan)|June 12, 2024
Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks Is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway InhibitorsYuya Yoshida, Masanobu Takahashi, Keigo Komine, et al.
The Tohoku Journal of Experimental Medicine|February 12, 2025
Outcomes of Chemotherapy for Advanced Esophageal Squamous Cell Carcinoma: A Study Using Real-World DataTomoyuki Iwasaki, Masanobu Takahashi, Kota Ouchi, et al.
Pageof 1